4
Changes in Ownership
Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-25-008620
CHIEF COMMERCIAL OFFICER acquired 1,118 shares (grant or award)
- CHIEF COMMERCIAL OFFICER gave up 292 shares (to pay taxes)
- CHIEF COMMERCIAL OFFICER acquired 994 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Moat Ross CHIEF COMMERCIAL OFFICER | 2025-01-15 | Grant or award | +1,118 | $16.00 | $17,888 | 22,854 | D |
| Moat Ross CHIEF COMMERCIAL OFFICER | 2025-03-16 | Option exercise | +994 | 23,848 | D | ||
| Moat Ross CHIEF COMMERCIAL OFFICER | 2025-03-16 | Shares withheld for taxes | −292 | $22.61 | $6,602 | 23,556 | D |
| Derivatives | |||||||
| Moat Ross CHIEF COMMERCIAL OFFICER | 2025-03-16 | Option exercise · Restricted Share Unit | −994 | 0 | D | ||
Loading xslF345X05/form4-03192025_090322.xml…